Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction

  • Park, Hun-Jun (Division of Cardiology, The Catholic University of Korea College of Medicine, Cardiovascular Center, Seoul St. Mary's Hospital)
  • Received : 2018.01.04
  • Accepted : 2018.01.25
  • Published : 2018.02.28
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Park HW, Yoon CH, Kang SH, et al. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol 2013;169:254-61. https://doi.org/10.1016/j.ijcard.2013.08.132
  2. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004;43:585-91. https://doi.org/10.1016/j.jacc.2003.08.050
  3. Park HW, Kang MG, Kim K, et al. Long-term prognosis and clinical characteristics of patients with newly diagnosed diabetes mellitus detected after the first acute myocardial infarction: from the KAMIR-NIH registry. Korean Circ J. 2018;48:134-47. https://doi.org/10.4070/kcj.2017.0174
  4. Aguilar D, Solomon SD, Kober L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 2004;110:1572-8. https://doi.org/10.1161/01.CIR.0000142047.28024.F2
  5. Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW. Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study). Am J Cardiol 2017;119:1917-23. https://doi.org/10.1016/j.amjcard.2017.03.016
  6. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5. https://doi.org/10.2337/dc16-S003
  7. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med 2016;164:542-52. https://doi.org/10.7326/M15-3016
  8. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-122. https://doi.org/10.1016/j.jacc.2011.08.007
  9. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med 2013;368:254-65. https://doi.org/10.1056/NEJMra1210816
  10. Bangalore S, Kumar S, Fusaro M, et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 2012;345:e5170. https://doi.org/10.1136/bmj.e5170